GLP-1 receptor agonists were originally approved for the treatment of type 2 diabetes, though given the prevalence of GLP-1 receptors in various peripheral tissues, more recent studies have started to look at additional etiologies for which GLP-1 agonists could be a feasible therapeutic option, including MASLD
Researchers are trying to figure out why Obesity shaped Anna Olson's earliest notions of herself, when she saw a photo and thought, "Oh, I look different than the other kids." Olson's obesity began in toddlerhood, ran in her family, and left her with a chronic hunger hard to satiate
Glucagon-like peptide-1 (GLP1) regulates blood sugar and appetite Glucose-dependent insulinotropic polypeptide (GIP) regulates insulin Glucagon controls blood sugar levels Together, these multiple pathways are all involved in appetite, satiety and digestive speed
The points below summarise what every adult considering this option should think through
Call/Text us at 312.312.7873 or book your appointment online today
